nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentolamine—Pain in jaw—Nicotine—ulcerative colitis	0.0434	0.0619	CcSEcCtD
Phentolamine—Tenderness—Nicotine—ulcerative colitis	0.0162	0.0231	CcSEcCtD
Phentolamine—Blood pressure increased—Nicotine—ulcerative colitis	0.0141	0.0202	CcSEcCtD
Phentolamine—Hypotensive—Betamethasone—ulcerative colitis	0.0132	0.0188	CcSEcCtD
Phentolamine—Hypotensive—Dexamethasone—ulcerative colitis	0.0132	0.0188	CcSEcCtD
Phentolamine—Nasal congestion—Nicotine—ulcerative colitis	0.0113	0.0161	CcSEcCtD
Phentolamine—Tenderness—Budesonide—ulcerative colitis	0.0112	0.0159	CcSEcCtD
Phentolamine—Abdominal pain upper—Nicotine—ulcerative colitis	0.00938	0.0134	CcSEcCtD
Phentolamine—SIGMAR1—Levonorgestrel—Hydrocortisone—ulcerative colitis	0.00931	1	CbGdCrCtD
Phentolamine—Tenderness—Mesalazine—ulcerative colitis	0.00908	0.013	CcSEcCtD
Phentolamine—Peptic ulcer—Prednisolone—ulcerative colitis	0.00863	0.0123	CcSEcCtD
Phentolamine—Peptic ulcer—Hydrocortisone—ulcerative colitis	0.00843	0.012	CcSEcCtD
Phentolamine—Peptic ulcer—Triamcinolone—ulcerative colitis	0.00793	0.0113	CcSEcCtD
Phentolamine—Peptic ulcer—Methylprednisolone—ulcerative colitis	0.00792	0.0113	CcSEcCtD
Phentolamine—Nasal congestion—Budesonide—ulcerative colitis	0.00776	0.0111	CcSEcCtD
Phentolamine—Peptic ulcer—Betamethasone—ulcerative colitis	0.0072	0.0103	CcSEcCtD
Phentolamine—Peptic ulcer—Dexamethasone—ulcerative colitis	0.0072	0.0103	CcSEcCtD
Phentolamine—Cardiac disorder—Nicotine—ulcerative colitis	0.00659	0.00941	CcSEcCtD
Phentolamine—Flushing—Nicotine—ulcerative colitis	0.00659	0.00941	CcSEcCtD
Phentolamine—Abdominal pain upper—Budesonide—ulcerative colitis	0.00646	0.00922	CcSEcCtD
Phentolamine—Mediastinal disorder—Nicotine—ulcerative colitis	0.0064	0.00914	CcSEcCtD
Phentolamine—Arrhythmia—Nicotine—ulcerative colitis	0.00634	0.00906	CcSEcCtD
Phentolamine—Peptic ulcer—Prednisone—ulcerative colitis	0.00627	0.00895	CcSEcCtD
Phentolamine—Hypertension—Nicotine—ulcerative colitis	0.00534	0.00762	CcSEcCtD
Phentolamine—Chest pain—Nicotine—ulcerative colitis	0.00526	0.00751	CcSEcCtD
Phentolamine—Orthostatic hypotension—Mesalazine—ulcerative colitis	0.00525	0.0075	CcSEcCtD
Phentolamine—Abdominal pain upper—Mesalazine—ulcerative colitis	0.00525	0.0075	CcSEcCtD
Phentolamine—Nervous system disorder—Nicotine—ulcerative colitis	0.00495	0.00706	CcSEcCtD
Phentolamine—Tachycardia—Nicotine—ulcerative colitis	0.00492	0.00703	CcSEcCtD
Phentolamine—Angina pectoris—Mesalazine—ulcerative colitis	0.00484	0.00691	CcSEcCtD
Phentolamine—Hypotension—Nicotine—ulcerative colitis	0.00471	0.00673	CcSEcCtD
Phentolamine—Cardiac disorder—Budesonide—ulcerative colitis	0.00454	0.00648	CcSEcCtD
Phentolamine—Flushing—Budesonide—ulcerative colitis	0.00454	0.00648	CcSEcCtD
Phentolamine—Paraesthesia—Nicotine—ulcerative colitis	0.00453	0.00647	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Mercaptopurine—ulcerative colitis	0.0045	0.00642	CcSEcCtD
Phentolamine—Angiopathy—Budesonide—ulcerative colitis	0.00444	0.00633	CcSEcCtD
Phentolamine—Mediastinal disorder—Budesonide—ulcerative colitis	0.00441	0.00629	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Nicotine—ulcerative colitis	0.00436	0.00622	CcSEcCtD
Phentolamine—Pain—Nicotine—ulcerative colitis	0.00431	0.00616	CcSEcCtD
Phentolamine—Gastrointestinal pain—Nicotine—ulcerative colitis	0.00413	0.00589	CcSEcCtD
Phentolamine—Abdominal pain—Nicotine—ulcerative colitis	0.00399	0.00569	CcSEcCtD
Phentolamine—Mediastinal disorder—Azathioprine—ulcerative colitis	0.00394	0.00562	CcSEcCtD
Phentolamine—Arrhythmia—Azathioprine—ulcerative colitis	0.0039	0.00557	CcSEcCtD
Phentolamine—Abdominal pain upper—Hydrocortisone—ulcerative colitis	0.00373	0.00533	CcSEcCtD
Phentolamine—Cardiac disorder—Mesalazine—ulcerative colitis	0.00369	0.00527	CcSEcCtD
Phentolamine—Hypertension—Budesonide—ulcerative colitis	0.00368	0.00525	CcSEcCtD
Phentolamine—Chest pain—Budesonide—ulcerative colitis	0.00363	0.00517	CcSEcCtD
Phentolamine—Asthenia—Nicotine—ulcerative colitis	0.00362	0.00517	CcSEcCtD
Phentolamine—Angiopathy—Mesalazine—ulcerative colitis	0.00361	0.00515	CcSEcCtD
Phentolamine—Mediastinal disorder—Mesalazine—ulcerative colitis	0.00359	0.00512	CcSEcCtD
Phentolamine—Pruritus—Nicotine—ulcerative colitis	0.00357	0.0051	CcSEcCtD
Phentolamine—Diarrhoea—Mercaptopurine—ulcerative colitis	0.00356	0.00509	CcSEcCtD
Phentolamine—Diarrhoea—Nicotine—ulcerative colitis	0.00345	0.00493	CcSEcCtD
Phentolamine—Nervous system disorder—Budesonide—ulcerative colitis	0.00341	0.00486	CcSEcCtD
Phentolamine—Tachycardia—Budesonide—ulcerative colitis	0.00339	0.00484	CcSEcCtD
Phentolamine—Dizziness—Nicotine—ulcerative colitis	0.00334	0.00476	CcSEcCtD
Phentolamine—Vomiting—Mercaptopurine—ulcerative colitis	0.00331	0.00473	CcSEcCtD
Phentolamine—Vomiting—Nicotine—ulcerative colitis	0.00321	0.00458	CcSEcCtD
Phentolamine—Acute coronary syndrome—Prednisolone—ulcerative colitis	0.00318	0.00454	CcSEcCtD
Phentolamine—Myocardial infarction—Prednisolone—ulcerative colitis	0.00316	0.00451	CcSEcCtD
Phentolamine—Headache—Nicotine—ulcerative colitis	0.00316	0.00451	CcSEcCtD
Phentolamine—Paraesthesia—Budesonide—ulcerative colitis	0.00312	0.00445	CcSEcCtD
Phentolamine—Acute coronary syndrome—Hydrocortisone—ulcerative colitis	0.00311	0.00443	CcSEcCtD
Phentolamine—Nausea—Mercaptopurine—ulcerative colitis	0.00309	0.00441	CcSEcCtD
Phentolamine—Myocardial infarction—Hydrocortisone—ulcerative colitis	0.00309	0.00441	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.003	0.00428	CcSEcCtD
Phentolamine—Nausea—Nicotine—ulcerative colitis	0.003	0.00428	CcSEcCtD
Phentolamine—Hypertension—Mesalazine—ulcerative colitis	0.00299	0.00427	CcSEcCtD
Phentolamine—Pain—Budesonide—ulcerative colitis	0.00297	0.00424	CcSEcCtD
Phentolamine—Bradycardia—Prednisolone—ulcerative colitis	0.00295	0.00421	CcSEcCtD
Phentolamine—Chest pain—Mesalazine—ulcerative colitis	0.00295	0.00421	CcSEcCtD
Phentolamine—Acute coronary syndrome—Triamcinolone—ulcerative colitis	0.00292	0.00417	CcSEcCtD
Phentolamine—Acute coronary syndrome—Methylprednisolone—ulcerative colitis	0.00292	0.00417	CcSEcCtD
Phentolamine—Myocardial infarction—Triamcinolone—ulcerative colitis	0.00291	0.00415	CcSEcCtD
Phentolamine—Myocardial infarction—Methylprednisolone—ulcerative colitis	0.0029	0.00414	CcSEcCtD
Phentolamine—Hypotension—Azathioprine—ulcerative colitis	0.0029	0.00414	CcSEcCtD
Phentolamine—Bradycardia—Hydrocortisone—ulcerative colitis	0.00288	0.00411	CcSEcCtD
Phentolamine—Gastrointestinal pain—Budesonide—ulcerative colitis	0.00284	0.00406	CcSEcCtD
Phentolamine—Nervous system disorder—Mesalazine—ulcerative colitis	0.00277	0.00396	CcSEcCtD
Phentolamine—Tachycardia—Mesalazine—ulcerative colitis	0.00276	0.00394	CcSEcCtD
Phentolamine—Abdominal pain—Budesonide—ulcerative colitis	0.00275	0.00392	CcSEcCtD
Phentolamine—Bradycardia—Triamcinolone—ulcerative colitis	0.00271	0.00387	CcSEcCtD
Phentolamine—Bradycardia—Methylprednisolone—ulcerative colitis	0.00271	0.00386	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.00268	0.00382	CcSEcCtD
Phentolamine—Acute coronary syndrome—Dexamethasone—ulcerative colitis	0.00265	0.00379	CcSEcCtD
Phentolamine—Acute coronary syndrome—Betamethasone—ulcerative colitis	0.00265	0.00379	CcSEcCtD
Phentolamine—Hypotension—Mesalazine—ulcerative colitis	0.00264	0.00377	CcSEcCtD
Phentolamine—Myocardial infarction—Betamethasone—ulcerative colitis	0.00264	0.00377	CcSEcCtD
Phentolamine—Myocardial infarction—Dexamethasone—ulcerative colitis	0.00264	0.00377	CcSEcCtD
Phentolamine—Arrhythmia—Prednisolone—ulcerative colitis	0.00259	0.00369	CcSEcCtD
Phentolamine—Paraesthesia—Mesalazine—ulcerative colitis	0.00254	0.00362	CcSEcCtD
Phentolamine—Gastrointestinal pain—Azathioprine—ulcerative colitis	0.00254	0.00362	CcSEcCtD
Phentolamine—Arrhythmia—Hydrocortisone—ulcerative colitis	0.00253	0.00361	CcSEcCtD
Phentolamine—Asthenia—Budesonide—ulcerative colitis	0.00249	0.00356	CcSEcCtD
Phentolamine—Cardiac disorder—Methylprednisolone—ulcerative colitis	0.00247	0.00352	CcSEcCtD
Phentolamine—Bradycardia—Betamethasone—ulcerative colitis	0.00246	0.00351	CcSEcCtD
Phentolamine—Bradycardia—Dexamethasone—ulcerative colitis	0.00246	0.00351	CcSEcCtD
Phentolamine—Pruritus—Budesonide—ulcerative colitis	0.00246	0.00351	CcSEcCtD
Phentolamine—Abdominal pain—Azathioprine—ulcerative colitis	0.00245	0.0035	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.00244	0.00348	CcSEcCtD
Phentolamine—Pain—Mesalazine—ulcerative colitis	0.00242	0.00345	CcSEcCtD
Phentolamine—Angiopathy—Methylprednisolone—ulcerative colitis	0.00241	0.00344	CcSEcCtD
Phentolamine—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.0024	0.00342	CcSEcCtD
Phentolamine—Arrhythmia—Triamcinolone—ulcerative colitis	0.00238	0.0034	CcSEcCtD
Phentolamine—Diarrhoea—Budesonide—ulcerative colitis	0.00238	0.00339	CcSEcCtD
Phentolamine—Arrhythmia—Methylprednisolone—ulcerative colitis	0.00237	0.00339	CcSEcCtD
Phentolamine—Acute coronary syndrome—Prednisone—ulcerative colitis	0.00231	0.0033	CcSEcCtD
Phentolamine—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.00231	0.0033	CcSEcCtD
Phentolamine—Myocardial infarction—Prednisone—ulcerative colitis	0.0023	0.00328	CcSEcCtD
Phentolamine—Dizziness—Budesonide—ulcerative colitis	0.0023	0.00328	CcSEcCtD
Phentolamine—Abdominal pain—Mesalazine—ulcerative colitis	0.00223	0.00319	CcSEcCtD
Phentolamine—Vomiting—Budesonide—ulcerative colitis	0.00221	0.00315	CcSEcCtD
Phentolamine—Angiopathy—Betamethasone—ulcerative colitis	0.00219	0.00313	CcSEcCtD
Phentolamine—Angiopathy—Dexamethasone—ulcerative colitis	0.00219	0.00313	CcSEcCtD
Phentolamine—Headache—Budesonide—ulcerative colitis	0.00218	0.00311	CcSEcCtD
Phentolamine—Hypertension—Prednisolone—ulcerative colitis	0.00218	0.00311	CcSEcCtD
Phentolamine—Arrhythmia—Betamethasone—ulcerative colitis	0.00216	0.00308	CcSEcCtD
Phentolamine—Arrhythmia—Dexamethasone—ulcerative colitis	0.00216	0.00308	CcSEcCtD
Phentolamine—Bradycardia—Prednisone—ulcerative colitis	0.00214	0.00306	CcSEcCtD
Phentolamine—Hypertension—Hydrocortisone—ulcerative colitis	0.00213	0.00303	CcSEcCtD
Phentolamine—Diarrhoea—Azathioprine—ulcerative colitis	0.00212	0.00303	CcSEcCtD
Phentolamine—Nausea—Budesonide—ulcerative colitis	0.00206	0.00295	CcSEcCtD
Phentolamine—Dizziness—Azathioprine—ulcerative colitis	0.00205	0.00293	CcSEcCtD
Phentolamine—Asthenia—Mesalazine—ulcerative colitis	0.00203	0.00289	CcSEcCtD
Phentolamine—Tachycardia—Prednisolone—ulcerative colitis	0.00201	0.00287	CcSEcCtD
Phentolamine—Hypertension—Triamcinolone—ulcerative colitis	0.002	0.00286	CcSEcCtD
Phentolamine—Pruritus—Mesalazine—ulcerative colitis	0.002	0.00285	CcSEcCtD
Phentolamine—Hypertension—Methylprednisolone—ulcerative colitis	0.002	0.00285	CcSEcCtD
Phentolamine—Vomiting—Azathioprine—ulcerative colitis	0.00197	0.00282	CcSEcCtD
Phentolamine—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.00197	0.00281	CcSEcCtD
Phentolamine—Tachycardia—Hydrocortisone—ulcerative colitis	0.00196	0.0028	CcSEcCtD
Phentolamine—Flushing—Prednisone—ulcerative colitis	0.00195	0.00279	CcSEcCtD
Phentolamine—Headache—Azathioprine—ulcerative colitis	0.00194	0.00277	CcSEcCtD
Phentolamine—Diarrhoea—Mesalazine—ulcerative colitis	0.00193	0.00276	CcSEcCtD
Phentolamine—Angiopathy—Prednisone—ulcerative colitis	0.00191	0.00273	CcSEcCtD
Phentolamine—Arrhythmia—Prednisone—ulcerative colitis	0.00188	0.00268	CcSEcCtD
Phentolamine—Hypotension—Hydrocortisone—ulcerative colitis	0.00188	0.00268	CcSEcCtD
Phentolamine—Dizziness—Mesalazine—ulcerative colitis	0.00187	0.00267	CcSEcCtD
Phentolamine—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.00185	0.00264	CcSEcCtD
Phentolamine—Paraesthesia—Prednisolone—ulcerative colitis	0.00185	0.00264	CcSEcCtD
Phentolamine—Tachycardia—Triamcinolone—ulcerative colitis	0.00185	0.00264	CcSEcCtD
Phentolamine—Nausea—Azathioprine—ulcerative colitis	0.00184	0.00263	CcSEcCtD
Phentolamine—Tachycardia—Methylprednisolone—ulcerative colitis	0.00184	0.00263	CcSEcCtD
Phentolamine—Hypertension—Dexamethasone—ulcerative colitis	0.00182	0.00259	CcSEcCtD
Phentolamine—Hypertension—Betamethasone—ulcerative colitis	0.00182	0.00259	CcSEcCtD
Phentolamine—Paraesthesia—Hydrocortisone—ulcerative colitis	0.0018	0.00258	CcSEcCtD
Phentolamine—Vomiting—Mesalazine—ulcerative colitis	0.0018	0.00256	CcSEcCtD
Phentolamine—Headache—Mesalazine—ulcerative colitis	0.00177	0.00253	CcSEcCtD
Phentolamine—Hypotension—Methylprednisolone—ulcerative colitis	0.00176	0.00252	CcSEcCtD
Phentolamine—Pain—Prednisolone—ulcerative colitis	0.00176	0.00251	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.00174	0.00248	CcSEcCtD
Phentolamine—Pain—Hydrocortisone—ulcerative colitis	0.00172	0.00245	CcSEcCtD
Phentolamine—Paraesthesia—Triamcinolone—ulcerative colitis	0.0017	0.00243	CcSEcCtD
Phentolamine—Paraesthesia—Methylprednisolone—ulcerative colitis	0.0017	0.00242	CcSEcCtD
Phentolamine—Nervous system disorder—Betamethasone—ulcerative colitis	0.00168	0.0024	CcSEcCtD
Phentolamine—Nervous system disorder—Dexamethasone—ulcerative colitis	0.00168	0.0024	CcSEcCtD
Phentolamine—Nausea—Mesalazine—ulcerative colitis	0.00168	0.0024	CcSEcCtD
Phentolamine—Tachycardia—Dexamethasone—ulcerative colitis	0.00168	0.00239	CcSEcCtD
Phentolamine—Tachycardia—Betamethasone—ulcerative colitis	0.00168	0.00239	CcSEcCtD
Phentolamine—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.00164	0.00235	CcSEcCtD
Phentolamine—Pain—Triamcinolone—ulcerative colitis	0.00162	0.00231	CcSEcCtD
Phentolamine—Hypotension—Dexamethasone—ulcerative colitis	0.0016	0.00229	CcSEcCtD
Phentolamine—Hypotension—Betamethasone—ulcerative colitis	0.0016	0.00229	CcSEcCtD
Phentolamine—Abdominal pain—Hydrocortisone—ulcerative colitis	0.00159	0.00227	CcSEcCtD
Phentolamine—Hypertension—Prednisone—ulcerative colitis	0.00158	0.00226	CcSEcCtD
Phentolamine—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.00154	0.0022	CcSEcCtD
Phentolamine—Paraesthesia—Dexamethasone—ulcerative colitis	0.00154	0.0022	CcSEcCtD
Phentolamine—Paraesthesia—Betamethasone—ulcerative colitis	0.00154	0.0022	CcSEcCtD
Phentolamine—Abdominal pain—Methylprednisolone—ulcerative colitis	0.00149	0.00213	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.00148	0.00212	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.00148	0.00212	CcSEcCtD
Phentolamine—Pain—Betamethasone—ulcerative colitis	0.00147	0.0021	CcSEcCtD
Phentolamine—Pain—Dexamethasone—ulcerative colitis	0.00147	0.0021	CcSEcCtD
Phentolamine—Nervous system disorder—Prednisone—ulcerative colitis	0.00147	0.00209	CcSEcCtD
Phentolamine—Tachycardia—Prednisone—ulcerative colitis	0.00146	0.00208	CcSEcCtD
Phentolamine—Asthenia—Hydrocortisone—ulcerative colitis	0.00144	0.00206	CcSEcCtD
Phentolamine—Pruritus—Hydrocortisone—ulcerative colitis	0.00142	0.00203	CcSEcCtD
Phentolamine—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.0014	0.002	CcSEcCtD
Phentolamine—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.0014	0.002	CcSEcCtD
Phentolamine—Diarrhoea—Hydrocortisone—ulcerative colitis	0.00138	0.00196	CcSEcCtD
Phentolamine—Dizziness—Prednisolone—ulcerative colitis	0.00136	0.00194	CcSEcCtD
Phentolamine—Asthenia—Triamcinolone—ulcerative colitis	0.00136	0.00194	CcSEcCtD
Phentolamine—Abdominal pain—Betamethasone—ulcerative colitis	0.00136	0.00194	CcSEcCtD
Phentolamine—Abdominal pain—Dexamethasone—ulcerative colitis	0.00136	0.00194	CcSEcCtD
Phentolamine—Asthenia—Methylprednisolone—ulcerative colitis	0.00135	0.00193	CcSEcCtD
Phentolamine—Paraesthesia—Prednisone—ulcerative colitis	0.00134	0.00192	CcSEcCtD
Phentolamine—Pruritus—Triamcinolone—ulcerative colitis	0.00134	0.00191	CcSEcCtD
Phentolamine—Pruritus—Methylprednisolone—ulcerative colitis	0.00134	0.00191	CcSEcCtD
Phentolamine—Dizziness—Hydrocortisone—ulcerative colitis	0.00133	0.0019	CcSEcCtD
Phentolamine—Diarrhoea—Methylprednisolone—ulcerative colitis	0.00129	0.00184	CcSEcCtD
Phentolamine—Headache—Prednisolone—ulcerative colitis	0.00129	0.00184	CcSEcCtD
Phentolamine—Vomiting—Hydrocortisone—ulcerative colitis	0.00128	0.00182	CcSEcCtD
Phentolamine—Headache—Hydrocortisone—ulcerative colitis	0.00126	0.0018	CcSEcCtD
Phentolamine—Dizziness—Triamcinolone—ulcerative colitis	0.00125	0.00179	CcSEcCtD
Phentolamine—Dizziness—Methylprednisolone—ulcerative colitis	0.00125	0.00178	CcSEcCtD
Phentolamine—Asthenia—Dexamethasone—ulcerative colitis	0.00123	0.00176	CcSEcCtD
Phentolamine—Asthenia—Betamethasone—ulcerative colitis	0.00123	0.00176	CcSEcCtD
Phentolamine—Gastrointestinal pain—Prednisone—ulcerative colitis	0.00122	0.00175	CcSEcCtD
Phentolamine—Nausea—Prednisolone—ulcerative colitis	0.00122	0.00174	CcSEcCtD
Phentolamine—Pruritus—Dexamethasone—ulcerative colitis	0.00121	0.00173	CcSEcCtD
Phentolamine—Pruritus—Betamethasone—ulcerative colitis	0.00121	0.00173	CcSEcCtD
Phentolamine—Vomiting—Triamcinolone—ulcerative colitis	0.0012	0.00172	CcSEcCtD
Phentolamine—Vomiting—Methylprednisolone—ulcerative colitis	0.0012	0.00171	CcSEcCtD
Phentolamine—Nausea—Hydrocortisone—ulcerative colitis	0.00119	0.0017	CcSEcCtD
Phentolamine—Headache—Triamcinolone—ulcerative colitis	0.00119	0.00169	CcSEcCtD
Phentolamine—Headache—Methylprednisolone—ulcerative colitis	0.00118	0.00169	CcSEcCtD
Phentolamine—Abdominal pain—Prednisone—ulcerative colitis	0.00118	0.00169	CcSEcCtD
Phentolamine—Diarrhoea—Dexamethasone—ulcerative colitis	0.00117	0.00168	CcSEcCtD
Phentolamine—Diarrhoea—Betamethasone—ulcerative colitis	0.00117	0.00168	CcSEcCtD
Phentolamine—Dizziness—Dexamethasone—ulcerative colitis	0.00114	0.00162	CcSEcCtD
Phentolamine—Dizziness—Betamethasone—ulcerative colitis	0.00114	0.00162	CcSEcCtD
Phentolamine—Nausea—Triamcinolone—ulcerative colitis	0.00112	0.0016	CcSEcCtD
Phentolamine—Nausea—Methylprednisolone—ulcerative colitis	0.00112	0.0016	CcSEcCtD
Phentolamine—Vomiting—Dexamethasone—ulcerative colitis	0.00109	0.00156	CcSEcCtD
Phentolamine—Vomiting—Betamethasone—ulcerative colitis	0.00109	0.00156	CcSEcCtD
Phentolamine—Headache—Dexamethasone—ulcerative colitis	0.00108	0.00154	CcSEcCtD
Phentolamine—Headache—Betamethasone—ulcerative colitis	0.00108	0.00154	CcSEcCtD
Phentolamine—Asthenia—Prednisone—ulcerative colitis	0.00107	0.00153	CcSEcCtD
Phentolamine—Pruritus—Prednisone—ulcerative colitis	0.00106	0.00151	CcSEcCtD
Phentolamine—Diarrhoea—Prednisone—ulcerative colitis	0.00102	0.00146	CcSEcCtD
Phentolamine—Nausea—Betamethasone—ulcerative colitis	0.00102	0.00146	CcSEcCtD
Phentolamine—Nausea—Dexamethasone—ulcerative colitis	0.00102	0.00146	CcSEcCtD
Phentolamine—Dizziness—Prednisone—ulcerative colitis	0.000989	0.00141	CcSEcCtD
Phentolamine—Vomiting—Prednisone—ulcerative colitis	0.000951	0.00136	CcSEcCtD
Phentolamine—Headache—Prednisone—ulcerative colitis	0.000937	0.00134	CcSEcCtD
Phentolamine—Nausea—Prednisone—ulcerative colitis	0.000888	0.00127	CcSEcCtD
Phentolamine—ADRA2C—Signaling by GPCR—GHRL—ulcerative colitis	0.000203	0.000701	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CXCR1—ulcerative colitis	0.000203	0.000699	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—GHRL—ulcerative colitis	0.0002	0.00069	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—SEL1L—ulcerative colitis	0.0002	0.000689	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—ADRB2—ulcerative colitis	0.0002	0.000688	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CXCR1—ulcerative colitis	0.000199	0.000687	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000199	0.000685	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000199	0.000684	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—GNA12—ulcerative colitis	0.000198	0.000684	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—CALM3—ulcerative colitis	0.000197	0.000679	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—GHRL—ulcerative colitis	0.000196	0.000675	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—PTGER4—ulcerative colitis	0.000194	0.00067	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—CALM3—ulcerative colitis	0.000194	0.000668	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CCL20—ulcerative colitis	0.00019	0.000657	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CXCR2—ulcerative colitis	0.000188	0.000648	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR ligand binding—CXCL8—ulcerative colitis	0.000188	0.000648	CbGpPWpGaD
Phentolamine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	0.000187	0.000645	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000187	0.000643	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000185	0.000639	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000182	0.000629	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—GHRL—ulcerative colitis	0.000182	0.000627	CbGpPWpGaD
Phentolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000182	0.000627	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—PTGER4—ulcerative colitis	0.00018	0.000622	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—ADRB2—ulcerative colitis	0.00018	0.000621	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—GNA12—ulcerative colitis	0.000179	0.000617	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—MMP1—ulcerative colitis	0.000179	0.000617	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—ALB—ulcerative colitis	0.000179	0.000616	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CCL20—ulcerative colitis	0.000178	0.000613	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—GHRL—ulcerative colitis	0.000178	0.000613	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CXCR1—ulcerative colitis	0.000177	0.000611	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CCR6—ulcerative colitis	0.000177	0.000609	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CCL20—ulcerative colitis	0.000175	0.000604	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—CALM3—ulcerative colitis	0.000172	0.000594	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CXCR2—ulcerative colitis	0.00017	0.000585	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR ligand binding—CXCL8—ulcerative colitis	0.00017	0.000585	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—ADCY5—ulcerative colitis	0.000169	0.000584	CbGpPWpGaD
Phentolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000169	0.000583	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000168	0.000581	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—ADRB2—ulcerative colitis	0.000168	0.00058	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—MAML2—ulcerative colitis	0.000168	0.000578	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—GNA12—ulcerative colitis	0.000167	0.000577	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—ALB—ulcerative colitis	0.000167	0.000576	CbGpPWpGaD
Phentolamine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	0.000166	0.000574	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—JAK2—ulcerative colitis	0.000166	0.000573	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—ADRB2—ulcerative colitis	0.000166	0.000571	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—GHRL—ulcerative colitis	0.000165	0.00057	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—GNA12—ulcerative colitis	0.000165	0.000567	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CXCR1—ulcerative colitis	0.000165	0.000567	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000162	0.000559	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—CALM3—ulcerative colitis	0.00016	0.000552	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CCR6—ulcerative colitis	0.00016	0.00055	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CXCR2—ulcerative colitis	0.000159	0.000547	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR ligand binding—CXCL8—ulcerative colitis	0.000158	0.000546	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000157	0.000543	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CXCR2—ulcerative colitis	0.000156	0.000538	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR ligand binding—CXCL8—ulcerative colitis	0.000156	0.000538	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—PTGER4—ulcerative colitis	0.000156	0.000537	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CCL20—ulcerative colitis	0.000156	0.000536	CbGpPWpGaD
Phentolamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	0.000155	0.000536	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—JAK2—ulcerative colitis	0.000155	0.000535	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000155	0.000534	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—PTGS1—ulcerative colitis	0.000155	0.000533	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—ADCY5—ulcerative colitis	0.000153	0.000527	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—MAML2—ulcerative colitis	0.000151	0.000522	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000151	0.000519	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CCR6—ulcerative colitis	0.000149	0.000514	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—ADRB2—ulcerative colitis	0.000147	0.000507	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CCR6—ulcerative colitis	0.000147	0.000506	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—GNA12—ulcerative colitis	0.000146	0.000504	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—IL2—ulcerative colitis	0.000145	0.0005	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CCL20—ulcerative colitis	0.000145	0.000498	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—ADCY5—ulcerative colitis	0.000143	0.000493	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—GHRL—ulcerative colitis	0.000142	0.000491	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—MAML2—ulcerative colitis	0.000141	0.000487	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—ADCY5—ulcerative colitis	0.000141	0.000485	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—PTGER4—ulcerative colitis	0.000141	0.000484	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—CALM3—ulcerative colitis	0.000139	0.00048	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—MAML2—ulcerative colitis	0.000139	0.000479	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CXCR2—ulcerative colitis	0.000139	0.000478	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR ligand binding—CXCL8—ulcerative colitis	0.000139	0.000478	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CALM3—ulcerative colitis	0.000138	0.000476	CbGpPWpGaD
Phentolamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	0.000138	0.000476	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000138	0.000474	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—ADRB2—ulcerative colitis	0.000137	0.000471	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—RIPK2—ulcerative colitis	0.000136	0.000469	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—GNA12—ulcerative colitis	0.000136	0.000468	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—ALB—ulcerative colitis	0.000136	0.000468	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—IL2—ulcerative colitis	0.000135	0.000467	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—PTGER4—ulcerative colitis	0.000131	0.000452	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CCR6—ulcerative colitis	0.00013	0.000449	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—PTGER4—ulcerative colitis	0.000129	0.000445	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CXCR2—ulcerative colitis	0.000129	0.000444	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR ligand binding—CXCL8—ulcerative colitis	0.000129	0.000444	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—GHRL—ulcerative colitis	0.000129	0.000443	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000128	0.000441	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—JAK2—ulcerative colitis	0.000126	0.000435	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PTGS1—ulcerative colitis	0.000126	0.000433	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—ADCY5—ulcerative colitis	0.000125	0.000431	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CALM3—ulcerative colitis	0.000125	0.000429	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—MAML2—ulcerative colitis	0.000124	0.000426	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—RIPK2—ulcerative colitis	0.000123	0.000423	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CCR6—ulcerative colitis	0.000121	0.000417	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—GHRL—ulcerative colitis	0.00012	0.000414	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—GHRL—ulcerative colitis	0.000118	0.000408	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—ADRB2—ulcerative colitis	0.000118	0.000407	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CALM3—ulcerative colitis	0.000116	0.000401	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—JAK2—ulcerative colitis	0.000116	0.000401	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—ADCY5—ulcerative colitis	0.000116	0.0004	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MAML2—ulcerative colitis	0.000115	0.000396	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PTGER4—ulcerative colitis	0.000115	0.000396	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—RIPK2—ulcerative colitis	0.000115	0.000395	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CALM3—ulcerative colitis	0.000115	0.000395	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—TGFB1—ulcerative colitis	0.000113	0.00039	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—CALM3—ulcerative colitis	0.000113	0.00039	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—RIPK2—ulcerative colitis	0.000113	0.000389	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—IL2—ulcerative colitis	0.00011	0.000379	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—ABCB1—ulcerative colitis	0.000108	0.000373	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PTGER4—ulcerative colitis	0.000107	0.000367	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—ADRB2—ulcerative colitis	0.000106	0.000367	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000106	0.000366	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—JAK2—ulcerative colitis	0.000106	0.000364	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—TGFB1—ulcerative colitis	0.000106	0.000364	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—GHRL—ulcerative colitis	0.000105	0.000362	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—JAK2—ulcerative colitis	0.000105	0.000362	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CALM3—ulcerative colitis	0.000102	0.000351	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—IL2—ulcerative colitis	0.000101	0.00035	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—ADCY5—ulcerative colitis	0.000101	0.000348	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—RIPK2—ulcerative colitis	0.0001	0.000345	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—ADCY5—ulcerative colitis	0.0001	0.000345	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—ADRB2—ulcerative colitis	9.95e-05	0.000343	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—JAK2—ulcerative colitis	9.81e-05	0.000338	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—ADRB2—ulcerative colitis	9.79e-05	0.000337	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—GHRL—ulcerative colitis	9.76e-05	0.000336	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—JAK2—ulcerative colitis	9.66e-05	0.000333	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—CXCL8—ulcerative colitis	9.64e-05	0.000332	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—CXCL8—ulcerative colitis	9.59e-05	0.00033	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—JAK2—ulcerative colitis	9.54e-05	0.000329	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CALM3—ulcerative colitis	9.45e-05	0.000326	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—RIPK2—ulcerative colitis	9.31e-05	0.000321	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—TP53—ulcerative colitis	9.31e-05	0.000321	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—IL2—ulcerative colitis	9.22e-05	0.000318	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—IL2—ulcerative colitis	9.16e-05	0.000316	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—ADCY5—ulcerative colitis	9.04e-05	0.000312	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—CXCL8—ulcerative colitis	8.96e-05	0.000309	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—JAK2—ulcerative colitis	8.91e-05	0.000307	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—CXCL8—ulcerative colitis	8.81e-05	0.000304	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—ABCB1—ulcerative colitis	8.79e-05	0.000303	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—JAK2—ulcerative colitis	8.77e-05	0.000302	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—CXCL8—ulcerative colitis	8.71e-05	0.0003	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—TP53—ulcerative colitis	8.7e-05	0.0003	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—ADRB2—ulcerative colitis	8.7e-05	0.0003	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—TGFB1—ulcerative colitis	8.58e-05	0.000296	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—JAK2—ulcerative colitis	8.58e-05	0.000296	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—IL2—ulcerative colitis	8.56e-05	0.000295	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—ADCY5—ulcerative colitis	8.44e-05	0.000291	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—IL2—ulcerative colitis	8.42e-05	0.00029	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—IL2—ulcerative colitis	8.32e-05	0.000287	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—ADCY5—ulcerative colitis	8.31e-05	0.000286	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—ADCY5—ulcerative colitis	8.2e-05	0.000283	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—CXCL8—ulcerative colitis	8.13e-05	0.00028	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—ADRB2—ulcerative colitis	8.08e-05	0.000279	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—CXCL8—ulcerative colitis	8e-05	0.000276	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—JAK2—ulcerative colitis	7.97e-05	0.000275	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—CXCL8—ulcerative colitis	7.83e-05	0.00027	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—JAK2—ulcerative colitis	7.79e-05	0.000269	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—IL2—ulcerative colitis	7.77e-05	0.000268	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—IL2—ulcerative colitis	7.65e-05	0.000264	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—PPARG—ulcerative colitis	7.53e-05	0.00026	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—IL2—ulcerative colitis	7.48e-05	0.000258	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—ADCY5—ulcerative colitis	7.38e-05	0.000254	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—CXCL8—ulcerative colitis	7.27e-05	0.000251	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—JAK2—ulcerative colitis	7.24e-05	0.000249	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—CXCL8—ulcerative colitis	7.11e-05	0.000245	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—TP53—ulcerative colitis	7.06e-05	0.000243	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—IL2—ulcerative colitis	6.95e-05	0.00024	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—ADCY5—ulcerative colitis	6.86e-05	0.000236	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—IL2—ulcerative colitis	6.79e-05	0.000234	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—ALB—ulcerative colitis	6.77e-05	0.000233	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—CXCL8—ulcerative colitis	6.61e-05	0.000228	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—IL2—ulcerative colitis	6.31e-05	0.000218	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—JAK2—ulcerative colitis	6.24e-05	0.000215	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PPARG—ulcerative colitis	6.12e-05	0.000211	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—RELA—ulcerative colitis	6.05e-05	0.000208	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—PTGS2—ulcerative colitis	5.92e-05	0.000204	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CXCL8—ulcerative colitis	5.7e-05	0.000196	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—JAK2—ulcerative colitis	5.64e-05	0.000194	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—ALB—ulcerative colitis	5.5e-05	0.00019	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—RELA—ulcerative colitis	5.46e-05	0.000188	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—IL2—ulcerative colitis	5.44e-05	0.000188	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—IL6—ulcerative colitis	5.42e-05	0.000187	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—JAK2—ulcerative colitis	5.26e-05	0.000181	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—JAK2—ulcerative colitis	5.18e-05	0.000179	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—MMP9—ulcerative colitis	5.15e-05	0.000178	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CXCL8—ulcerative colitis	5.14e-05	0.000177	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—RELA—ulcerative colitis	5.1e-05	0.000176	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—NFKB1—ulcerative colitis	5.1e-05	0.000176	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—RELA—ulcerative colitis	5.02e-05	0.000173	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IL2—ulcerative colitis	4.92e-05	0.000169	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—IL6—ulcerative colitis	4.89e-05	0.000169	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PTGS2—ulcerative colitis	4.81e-05	0.000166	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CXCL8—ulcerative colitis	4.8e-05	0.000166	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CXCL8—ulcerative colitis	4.73e-05	0.000163	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—MMP9—ulcerative colitis	4.65e-05	0.00016	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—NFKB1—ulcerative colitis	4.6e-05	0.000159	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—JAK2—ulcerative colitis	4.6e-05	0.000159	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IL2—ulcerative colitis	4.59e-05	0.000158	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—STAT3—ulcerative colitis	4.58e-05	0.000158	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—IL6—ulcerative colitis	4.57e-05	0.000157	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IL2—ulcerative colitis	4.52e-05	0.000156	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—IL6—ulcerative colitis	4.5e-05	0.000155	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—RELA—ulcerative colitis	4.46e-05	0.000154	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—MMP9—ulcerative colitis	4.35e-05	0.00015	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—NFKB1—ulcerative colitis	4.3e-05	0.000148	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—MMP9—ulcerative colitis	4.28e-05	0.000147	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—JAK2—ulcerative colitis	4.28e-05	0.000147	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—TGFB1—ulcerative colitis	4.25e-05	0.000146	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—NFKB1—ulcerative colitis	4.23e-05	0.000146	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CXCL8—ulcerative colitis	4.2e-05	0.000145	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—RELA—ulcerative colitis	4.14e-05	0.000143	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—STAT3—ulcerative colitis	4.14e-05	0.000143	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IL2—ulcerative colitis	4.01e-05	0.000138	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—IL6—ulcerative colitis	3.99e-05	0.000138	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CXCL8—ulcerative colitis	3.9e-05	0.000135	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—STAT3—ulcerative colitis	3.86e-05	0.000133	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—TGFB1—ulcerative colitis	3.83e-05	0.000132	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—STAT3—ulcerative colitis	3.8e-05	0.000131	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—MMP9—ulcerative colitis	3.8e-05	0.000131	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—NFKB1—ulcerative colitis	3.76e-05	0.00013	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IL2—ulcerative colitis	3.73e-05	0.000129	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—IL6—ulcerative colitis	3.71e-05	0.000128	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—TGFB1—ulcerative colitis	3.58e-05	0.000123	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MMP9—ulcerative colitis	3.53e-05	0.000122	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—TGFB1—ulcerative colitis	3.52e-05	0.000121	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—TP53—ulcerative colitis	3.5e-05	0.000121	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—NFKB1—ulcerative colitis	3.49e-05	0.00012	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—STAT3—ulcerative colitis	3.38e-05	0.000116	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—IL6—ulcerative colitis	3.2e-05	0.00011	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—TP53—ulcerative colitis	3.16e-05	0.000109	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—STAT3—ulcerative colitis	3.14e-05	0.000108	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—TGFB1—ulcerative colitis	3.13e-05	0.000108	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—TP53—ulcerative colitis	2.95e-05	0.000102	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—TGFB1—ulcerative colitis	2.91e-05	0.0001	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—TP53—ulcerative colitis	2.9e-05	0.0001	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IL6—ulcerative colitis	2.89e-05	9.96e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IL6—ulcerative colitis	2.7e-05	9.3e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IL6—ulcerative colitis	2.66e-05	9.16e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—TP53—ulcerative colitis	2.58e-05	8.88e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—TP53—ulcerative colitis	2.39e-05	8.25e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IL6—ulcerative colitis	2.36e-05	8.13e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IL6—ulcerative colitis	2.19e-05	7.56e-05	CbGpPWpGaD
